INCYTOИ GmbH

“Automate your cell-based assay and make it more efficient with the smart and made-in-Germany technologies from INCYTOИ”

Indication
Medical and Laboratory devices
Year founded
2018
Number of employees
7
Financing/Partnering
needs Business angels, distributors for national and international market, collaboration with public&private research centers and pharma industry

Team INCYTOИ

Address

Innovation and Start-Up Center for Biotechnology
Am Klopferspitz 19A
82152 Planegg
E-Mail: info@incyton.com
Web: www.incyton.com

Business concept

INCYTOИ multi-sensor systems monitor different cellular key parameters simultaneously, in real time and label free. Our technology records each single event, giving the user full control at every time-point without the need to be constantly present. A highly automated testing process dramatically reduces the time spent carrying out even the most complex assays – and this is done without affecting the quality of the research results.

INCYTOИ smart technologies are combined in one housing, creating a global environmental control (humidity, temperature, gas atmosphere) for all processes and reducing variations due to human influence. Having an incubator together with the measuring devices and treatment station reduces the risk of contamination. The results of your assays will, therefore, be more reliable and accurate.

Product/USP

Put your feet up and let technology do the work! With the INCYTOИ smart lab technology, you have an incubator together with measuring devices and treatment station, all housed in one place. It is the best of automation combined with accurate and reliable research results, in much less time.

Market potential

The market for cell-based assays – divided into the main categories of products (85%) and services (15%) – was worth around 19 billion EUR in 2018, with a CAGR (compound annual growth rate) of 16.5% by 2020.

The main INCYTOИ product can be classified as a high-content screening platform and belongs to the label-free technologies segment. For this market area a TAM (total addressable market) of around 186 million EUR can be estimated.

Achievements/Milestones

2017: Invitation to ASMRM 14th annual meeting (Asian society for mitochondrial Research and Medicine) as speaker,
2008-today: many publications on international peer-reviewed journals, based on research findings produced using INCYTOИ technology (Visit our website to know more),
2019: registration of INCYTOИ brand as global trademark,
2019: entry on the Chinese market.

Social Media

 

 

Hier kostenfrei für den Newsletter anmelden!